Aquapharm appoints Dr Simon Best OBE FRSE as new CEO
Current CEO and founder, Andrew Mearns Spragg, to take position as CTO
24-Mar-2010 -
Aquapharm Biodiscovery announced the close of a £4.2 million investment from existing investors Aescap Venture, Tate & Lyle Ventures, Highlands and Islands Enterprise and NESTA. Alongside the completion of the financing, Aquapharm has appointed the biotech entrepreneur Simon Best as CEO. Current ...
chemicals
enzymes
Formation
+3